Literature DB >> 34950301

High Cerebrovascular Thromboembolic Event Rate Long after Unsuccessful Catheter Ablation for Atrial Fibrillation.

Zsuzsanna Kis1, Mihran Martirosyan1, Astrid Armanda Hendriks1, Dominic Theuns1, Rohit Bhagwandien1, Sip Wijchers1, Sing-Chien Yap1, Tamas Szili-Torok1.   

Abstract

BACKGROUND: Although catheter ablation (CA) is an accepted therapeutic option for atrial fibrillation (AF), data is lacking concerning the long-term thromboembolic event (TE) and mortality rate of patients after unsuccessful CA for AF.
OBJECTIVE: The aim of the current study was to detect the long-term TE and mortality rate of patients with successful CA (group A) of AF and compared those with unsuccessful ablation (group B).
METHODS: Following a 4-years of follow-up (FU) 330 patients were included into the groupA, and 105 patients into the group B. Primary outcome was defined as all stroke/TIA occurrence. Secondary outcome was considered as all-cause mortality and stroke - and TIA only occurrence.
RESULTS: Seventeen patients developed a stroke/TIA during a median of 5.8 [5.1-7.3] years of FU. In the group A 8 (2.4%) patients developed a stroke/TIA during a FU of 2037 person-years (incidence rate 3.92 per 1000 person-years), compared to 9 patients in the group B during a FU of 726 person-years (incidence rate 12.4 per 1000 person-years). The crude HR for primary outcome was 2.84 (95% CI 1.078-7.48) in the group B compared with the group A. Cumulative TIA-alone incidence (3.97, CI 1.10-14.34, p=0.035) and the annualized TIA-alone incidence rate was significantly higher in the group B. (p=0.029). Neither the mortality rate nor the incidence rate of stroke-alone differed significantly among the groups.
CONCLUSIONS: The risk of all stroke/TIA and TIA-alone is higher among patients after unsuccessful CA of AF compared to those after successful ablation.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Ischemic stroke; Long-term follow-up

Year:  2020        PMID: 34950301      PMCID: PMC8691342          DOI: 10.4022/jafib.2294

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  17 in total

1.  Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death.

Authors:  Ross J Hunter; James McCready; Ihab Diab; Stephen P Page; Malcolm Finlay; Laura Richmond; Antony French; Mark J Earley; Simon Sporton; Michael Jones; Jubin P Joseph; Yaver Bashir; Tim R Betts; Glyn Thomas; Andrew Staniforth; Geoffrey Lee; Peter Kistler; Kim Rajappan; Anthony Chow; Richard J Schilling
Journal:  Heart       Date:  2011-09-19       Impact factor: 5.994

Review 2.  Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis.

Authors:  Antti Hakalahti; Fausto Biancari; Jens Cosedis Nielsen; M J Pekka Raatikainen
Journal:  Europace       Date:  2015-02-01       Impact factor: 5.214

3.  Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: A propensity score-matched analysis.

Authors:  Walid Saliba; Jorge E Schliamser; Idit Lavi; Ofra Barnett-Griness; Naomi Gronich; Gad Rennert
Journal:  Heart Rhythm       Date:  2017-02-09       Impact factor: 6.343

4.  Thromboembolic events 7-11 years after catheter ablation of atrial fibrillation.

Authors:  Van Nam Tran; Elena Tessitore; Pascale Gentil-Baron; Anne-Sophie Jannot; Henri Sunthorn; Haran Burri; François Mach; Dipen Shah
Journal:  Pacing Clin Electrophysiol       Date:  2015-01-28       Impact factor: 1.976

5.  Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries.

Authors:  Leif Friberg; Fariborz Tabrizi; Anders Englund
Journal:  Eur Heart J       Date:  2016-03-16       Impact factor: 29.983

6.  Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score.

Authors:  T Jared Bunch; Heidi T May; Tami L Bair; J Peter Weiss; Brian G Crandall; Jeffrey S Osborn; Charles Mallender; Jeffrey L Anderson; Brent J Muhlestein; Donald L Lappe; John D Day
Journal:  Heart Rhythm       Date:  2013-07-05       Impact factor: 6.343

7.  Risk of Stroke and Recurrence After AF Ablation in Patients With an Initial Event-Free Period of 12 Months.

Authors:  Simon Kochhäuser; Pouria Alipour; Tanjah Haig-Carter; Kathleen Trought; Philip Hache; Yaariv Khaykin; Zaev Wulffhart; Alfredo Pantano; Bernice Tsang; David Birnie; Atul Verma
Journal:  J Cardiovasc Electrophysiol       Date:  2017-01-11

8.  Mortality and cerebrovascular events after radiofrequency catheter ablation of atrial fibrillation.

Authors:  Hamid Ghanbari; Kazım Başer; Krit Jongnarangsin; Aman Chugh; Brahmajee K Nallamothu; Brenda W Gillespie; Hatice Duygu Başer; Arisara Suwanagool; Arisara Swangasool; Thomas Crawford; Rakesh Latchamsetty; Eric Good; Frank Pelosi; Frank Bogun; Fred Morady; Hakan Oral
Journal:  Heart Rhythm       Date:  2014-05-06       Impact factor: 6.343

9.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.

Authors:  Carlos A Morillo; Atul Verma; Stuart J Connolly; Karl H Kuck; Girish M Nair; Jean Champagne; Laurence D Sterns; Heather Beresh; Jeffrey S Healey; Andrea Natale
Journal:  JAMA       Date:  2014-02-19       Impact factor: 56.272

10.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.

Authors:  David J Wilber; Carlo Pappone; Petr Neuzil; Angelo De Paola; Frank Marchlinski; Andrea Natale; Laurent Macle; Emile G Daoud; Hugh Calkins; Burr Hall; Vivek Reddy; Giuseppe Augello; Matthew R Reynolds; Chandan Vinekar; Christine Y Liu; Scott M Berry; Donald A Berry
Journal:  JAMA       Date:  2010-01-27       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.